Tarrytown, NY, United States of America

Adam Locke

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.8

ph-index = 1


Location History:

  • Tarrytown, NY (US) (2023 - 2024)
  • Fort Dix, NJ (US) (2024)

Company Filing History:


Years Active: 2023-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Adam Locke: Innovator in Liver Disease Treatment

Introduction

Adam Locke is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medical treatments, particularly focusing on liver diseases and type 2 diabetes. With a total of 4 patents to his name, Locke's work is paving the way for innovative therapeutic methods.

Latest Patents

Locke's latest patents include groundbreaking methods for treating liver diseases using phosphodiesterase 3B (PDE3B) inhibitors. This patent outlines methods for treating subjects with liver disease or type 2 diabetes, as well as identifying individuals at increased risk for these conditions. Another significant patent focuses on the treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors. This disclosure provides methods for treating subjects with liver disease and identifying those at risk of developing such conditions.

Career Highlights

Throughout his career, Adam Locke has worked with prominent companies, including Regeneron Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Locke has collaborated with notable colleagues, including Niek Verweij and Luca Andrea Lotta. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic methods.

Conclusion

Adam Locke's contributions to the field of liver disease treatment exemplify the impact of innovation in medicine. His patents and collaborations highlight the importance of research and development in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…